AstraZeneca Pharma India gets CDSCO nod to import pharmaceutical formulations of Eculizumab Ruchika Sharma17 Jan 2025 1:32 PM ISTBangalore: AstraZeneca Pharma India Limited has received permission to import pharmaceutical formulations of new drug for sale or for...
Switching from eculizumab to ravulizumab safely preserves renal function in atypical hemolytic uremic syndrome: Study Dr. Shravani Dali25 July 2024 8:00 PM ISTSwitching from eculizumab to ravulizumab safely preserves renal function in atypical hemolytic uremic syndrome suggests a study published in the BMC...
Roche gets USFDA nod for chronic blood disorder treatment Crovalimab Ruchika Sharma23 Jun 2024 4:30 PM ISTRoche has received approval from the U.S. Food and Drug Administration (USFDA) for Crovalimab for the treatment of chronic blood...
AstraZeneca Pharma India Gets CDSCO Panel Nod To Import, Market Eculizumab for Atypical hemolytic uremic syndrome Dr. Divya Colin27 May 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca Pharma India has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
AstraZeneca Gets CDCSO Panel Nod to Import, market Eculizumab to treat Paroxysmal Nocturnal Hemoglobinuria Dr. Divya Colin29 April 2024 6:00 PM ISTNew Delhi: Noting that there is an unmet medical need in India, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca Voydeya approved in EU as add-on treatment to ravulizumab or eculizumab for adults with PNH who have residual haemolytic anaemia Ruchika Sharma26 April 2024 4:10 PM ISTAstraZeneca has announced that Voydeya (danicopan) has been approved in the European Union (EU) as an add-on to ravulizumab or...
USFDA nod to Voydeya as add on therapy to ravulizumab or eculizumab for extravascular haemolysis in adults with rare disease PNH: AstraZeneca Ruchika Sharma1 April 2024 3:18 PM ISTCambridge: AstraZeneca has announced that Voydeya (danicopan) has been approved in the US as add-on therapy to ravulizumab or eculizumab for the...
AstraZeneca blood disorder drug recommended for EU nod Ruchika Sharma27 Feb 2024 11:29 AM ISTCambridge: AstraZeneca has announced that Voydeya (danicopan) has been recommended for marketing authorisation in the European Union (EU) as an...
AstraZeneca Soliris approved in China for the treatment of adults with neuromyelitis optica spectrum disorder Ruchika Sharma22 Oct 2023 4:00 PM ISTCambridge: AstraZeneca has announced that Soliris (eculizumab) has been approved in China for the treatment of adult patients with neuromyelitis...
Eculizumab Mitigates Long-Term Kidney Damage in Pediatric Patients Jacinthlyn Sylvia22 Sept 2023 8:00 PM ISTShiga toxin-related hemolytic uremic syndrome (STEC-HUS), a rare and severe condition primarily affecting children, has long posed a significant...
AstraZeneca Soliris approved in Japan for paediatric patients with generalised myasthenia gravis Ruchika Sharma29 Aug 2023 4:14 PM ISTCambridge: AstraZeneca's Soliris (eculizumab) has been approved in Japan for expanded use to include the treatment of generalised myasthenia gravis...
AstraZeneca Soliris approved in EU for children, adolescents with refractory generalised myasthenia gravis Ruchika Sharma28 July 2023 2:30 PM ISTSoliris (eculizumab) is a first-in-class C5 complement inhibitor.
